Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

1.

From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia.

Schönfeldt-Lecuona C, Kregel T, Schmidt A, Pinkhardt EH, Lauda F, Kassubek J, Connemann BJ, Freudenmann RW, Gahr M.

Schizophr Bull. 2015 Jun 5. pii: sbv073. [Epub ahead of print]

PMID:
26048298
2.

Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Keller J, Gorges M, Horn HT, Aho-Özhan HE, Pinkhardt EH, Uttner I, Kassubek J, Ludolph AC, Lulé D.

J Neurol. 2015 Jun 5. [Epub ahead of print]

PMID:
26041615
3.

The association between alterations of eye movement control and cerebral intrinsic functional connectivity in Parkinson's disease.

Gorges M, Müller HP, Lulé D; LANDSCAPE Consortium, Pinkhardt EH, Ludolph AC, Kassubek J.

Brain Imaging Behav. 2015 Mar 10. [Epub ahead of print]

PMID:
25749936
4.

To rise and to fall: functional connectivity in cognitively normal and cognitively impaired patients with Parkinson's disease.

Gorges M, Müller HP, Lulé D; LANDSCAPE Consortium, Pinkhardt EH, Ludolph AC, Kassubek J.

Neurobiol Aging. 2015 Apr;36(4):1727-35. doi: 10.1016/j.neurobiolaging.2014.12.026. Epub 2014 Dec 31.

PMID:
25623332
5.

Frontal corpus callosum alterations in progressive supranuclear palsy but not in Parkinson's disease.

Rosskopf J, Müller HP, Huppertz HJ, Ludolph AC, Pinkhardt EH, Kassubek J.

Neurodegener Dis. 2014;14(4):184-93. doi: 10.1159/000367693. Epub 2014 Nov 1.

PMID:
25377379
6.

[Optical Coherence Tomography (OCT)--a new diagnostic tool in psychiatry?].

Schönfeldt-Lecuona C, Schmidt A, Pinkhardt EH, Lauda F, Connemann BJ, Freudenmann RW, Gahr M.

Fortschr Neurol Psychiatr. 2014 Oct;82(10):566-71. doi: 10.1055/s-0034-1385024. Epub 2014 Oct 9. Review. German.

PMID:
25299627
7.

Alterations of eye movement control in neurodegenerative movement disorders.

Gorges M, Pinkhardt EH, Kassubek J.

J Ophthalmol. 2014;2014:658243. doi: 10.1155/2014/658243. Epub 2014 May 18. Review.

8.

Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology.

Kassubek J, Müller HP, Del Tredici K, Brettschneider J, Pinkhardt EH, Lulé D, Böhm S, Braak H, Ludolph AC.

Brain. 2014 Jun;137(Pt 6):1733-40. doi: 10.1093/brain/awu090. Epub 2014 Apr 15.

9.

Do eye movement impairments in patients with small vessel cerebrovascular disease depend on lesion load or on cognitive deficits? A video-oculographic and MRI study.

Pinkhardt EH, Issa H, Gorges M, Jürgens R, Lulé D, Heimrath J, Müller HP, Ludolph AC, Becker W, Kassubek J.

J Neurol. 2014 Apr;261(4):791-803. doi: 10.1007/s00415-014-7275-1. Epub 2014 Feb 18.

PMID:
24535136
10.

[Botulinum toxin for the treatment of major depressive disorder].

Hawlik AE, Freudenmann RW, Pinkhardt EH, Schönfeldt-Lecuona CJ, Gahr M.

Fortschr Neurol Psychiatr. 2014 Feb;82(2):93-9. doi: 10.1055/s-0033-1356093. Epub 2014 Feb 11. Review. German.

PMID:
24519192
11.

Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study.

Schneider M, Müller HP, Lauda F, Tumani H, Ludolph AC, Kassubek J, Pinkhardt EH.

J Neural Transm. 2014 Jan;121(1):41-7. doi: 10.1007/s00702-013-1072-3. Epub 2013 Aug 2.

PMID:
23907408
12.

[The eye as a window to the pathophysiology in Parkinson's syndromes].

Kassubek J, Danek A, Del Tredici-Braak K, Greenlee MW, Pinkhardt EH.

Nervenarzt. 2013 Aug;84(8):909-17. doi: 10.1007/s00115-013-3754-3. Review. German.

PMID:
23760595
13.

Functional connectivity within the default mode network is associated with saccadic accuracy in Parkinson's disease: a resting-state FMRI and videooculographic study.

Gorges M, Müller HP, Lulé D, Ludolph AC, Pinkhardt EH, Kassubek J.

Brain Connect. 2013;3(3):265-72. doi: 10.1089/brain.2013.0146.

PMID:
23627641
14.

Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study.

Karcher HS, Holzwarth R, Mueller HP, Ludolph AC, Huber R, Kassubek J, Pinkhardt EH.

Cerebrovasc Dis. 2013;35(4):341-8. doi: 10.1159/000348703. Epub 2013 Apr 23.

PMID:
23615579
15.

Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms.

Pinkhardt EH, Jürgens R, Lulé D, Heimrath J, Ludolph AC, Becker W, Kassubek J.

BMC Neurol. 2012 Feb 29;12:5. doi: 10.1186/1471-2377-12-5.

16.

The cerebro-morphological fingerprint of a progeroid syndrome: white matter changes correlate with neurological symptoms in xeroderma pigmentosum.

Kassubek J, Sperfeld AD, Pinkhardt EH, Unrath A, Müller HP, Scharffetter-Kochanek K, Ludolph AC, Berneburg M.

PLoS One. 2012;7(2):e30926. doi: 10.1371/journal.pone.0030926. Epub 2012 Feb 21.

17.

Deep brain stimulation and behavioural changes: is comedication the most important factor?

Lulé D, Heimrath J, Pinkhardt EH, Ludolph AC, Uttner I, Kassubek J.

Neurodegener Dis. 2012;9(1):18-24. doi: 10.1159/000328817. Epub 2011 Jul 21.

PMID:
21778695
18.

Neural reward processing under dopamine agonists: imaging.

Kassubek J, Abler B, Pinkhardt EH.

J Neurol Sci. 2011 Nov 15;310(1-2):36-9. doi: 10.1016/j.jns.2011.06.043. Epub 2011 Jul 16. Review.

PMID:
21762926
19.

Fully automated atlas-based MR imaging volumetry in Huntington disease, compared with manual volumetry.

Kassubek J, Pinkhardt EH, Dietmaier A, Ludolph AC, Landwehrmeyer GB, Huppertz HJ.

AJNR Am J Neuroradiol. 2011 Aug;32(7):1328-32. doi: 10.3174/ajnr.A2514. Epub 2011 Jun 16.

20.

Ocular motor abnormalities in Parkinsonian syndromes.

Pinkhardt EH, Kassubek J.

Parkinsonism Relat Disord. 2011 May;17(4):223-30. doi: 10.1016/j.parkreldis.2010.08.004. Epub 2010 Aug 30. Review.

PMID:
20801069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk